Disease | malignant peripheral nerve sheath tumor |
Comorbidity | C1261473|sarcoma |
Sentences | 3 |
PubMedID- 23161774 | In the combined patient series from the 3 european sarcoma centers, 35% of the mpnst patients were diagnosed with nf1 (table 1)—33% in the norwegian series, 38% in the swedish series, and 36% in the italian series (supplementary tables 1–3). |
PubMedID- 24131748 | We caution readers against assuming any spindle cell tumor with epithelial immunolabeling to be synovial sarcoma, as 3/6 of our mpnst cases had ck and ema expression, which is comparable to previous studies and may have been due to cross-reactivity with schwannian components [12], and one must be cognizant of mpnst subtypes (epithelial and perineurial) with an epithelial immunophenotype. |
PubMedID- 24618071 | Differential diagnosis included synovial sarcoma, anaplastic meningioma with epithelial metaplasia, malignant peripheral nerve sheath tumor, and metastatic carcinosarcoma. |
Page: 1